1,042 results on '"Köbel, Martin"'
Search Results
152. Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.
153. Cervical Small Cell Neuroendocrine Carcinoma With Ectopic ACTH Secretion and Acute Pancreatitis.
154. BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
155. Cellular context determines DNA methylation profiles in SWI/SNF‐deficient cancers of the gynecologic tract
156. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas
157. Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma
158. Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
159. Calculator for ovarian carcinoma subtype prediction
160. Molecular Pathology of Ovarian Carcinomas
161. The Evolution of Ovarian Carcinoma Subclassification
162. Testing Algorithms for the Diagnosis of Malignant Glandular Tumors of the Uterine Cervix Histotyped per the International Endocervical Adenocarcinoma Criteria and Classification (IECC) System
163. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
164. The utility of color normalization for AI ‐based diagnosis of hematoxylin and eosin‐stained pathology images
165. Protracted clinical course of an AFF1 fusion positive uterine smooth muscle tumor causing diagnostic confusion over a course of 15 years
166. Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy
167. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
168. Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status
169. Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features
170. Efficient molecular subtype classification of high-grade serous ovarian cancer
171. Targeted mutation analysis of endometrial clear cell carcinoma
172. IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
173. Abstract 1045: Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy
174. Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
175. Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix
176. Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research
177. A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis
178. Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
179. The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma
180. Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry
181. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma—diagnostic utility of HNF-1β and oestrogen receptor
182. Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression.
183. Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes
184. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis
185. Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes
186. Prognostic and Theranostic Biomarkers in Ovarian Clear Cell Carcinoma
187. Dedifferentiation in Breast Metastasis of Endometrial Carcinoma
188. Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies
189. Abstract PO028: Embryonic protein NODAL as a potential modulator of the tumour microenvironment: Breast cancer secretome reprogramming and fibroblast activation
190. p53 immunohistochemical analysis of fusion‐positive uterine sarcomas
191. Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review
192. Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
193. Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3
194. Additional file 2 of Ovarian cancer: diagnostic accuracy and tumor types distribution in East Africa compared to North America
195. Additional file 1 of Ovarian cancer: diagnostic accuracy and tumor types distribution in East Africa compared to North America
196. New Views of Ovarian Carcinoma Types: How Will This Change Practice?
197. PODO447:a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin
198. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.
199. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers
200. Clinical and pathological associations of PTEN expression in ovarian cancer:a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.